Jan 22,2021

OncoHost Secures $8 Million Series B Funding Round

OncoHost, a global leader in technology involving host response profiling and personalized cancer therapy, has completed a $8 million Series B funding round. The new funding will help advance the company’s AI-powered precision oncology platform.

FUNDING SERIES B
View Analyst & Ambassador Comments
Go to original news
Feb 11,2021

Elekta launches Kaiku Health in the United States

In May 2020, Elekta announced that it will further develop its focus on cancer care providers and their patients through its acquisition of Kaiku Health. A key element of the acquisition was that the Kaiku platform can be integrated with Elekta’s MOSAIQ® Oncology Information System. Kaiku Health is now available in the US as a part of MOSAIQ Plaza. Today, the patient reported outcomes data, captured through Kaiku Health, is automatically available within MOSAIQ. Next, Kaiku Health will provide access to treatment appointment data for a convenient patient reference.

PRODUCT

#platform

View Analyst & Ambassador Comments
Go to original news
Feb 25,2021

Vinehealth Partners with the National Hospital for Neurology and Neurosurgery

Vinehealth is delighted to announce their collaboration with the National Hospital for Neurology and Neurosurgery (NHNN). Together the two parties will empower brain cancer patients to actively engage in their care using the Vinehealth app and current care pathways at NHNN to improve the patient experiences and provide remote, personalised support. Patients using the Vinehealth platform will be able to report back in a convenient and friendly way through the app, providing collective insight into better understanding the needs of brain cancer patients in COVID-19.

COLLABORATION PARTNERSHIP

#institution

#mobile app

#rpm

View Analyst & Ambassador Comments
Go to original news
Feb 22,2021

Carevive Closes Oversubscribed $18M Series C Equity Raise

Carevive Systems (Carevive), the leading oncology-focused health technology company centered on understanding and improving the cancer patient experience, has today announced the completion of a Series C equity investment of $18 million. The oversubscribed $18 million equity round was led by Philips Health Technology Ventures, and also includes Debiopharm Innovation Fund, and OurCrowd’s digital health fund, Qure Ventures, as well as prior investors HLM Venture Partners, LRVHealth, Cerner, and founder Madelyn Trupkin Herzfeld.

FUNDING SERIES C
View Analyst & Ambassador Comments
Go to original news
Feb 19,2021

Web-based self-help intervention for partners of cancer patients based on acceptance and commitment therapy and self-compassion training: a randomized controlled trial with automated versus personal feedback

The study is to evaluate the effectiveness of two versions (personal or automated feedback) of a psychological Web-based self-help intervention targeting partners of cancer patients. The intervention was based on acceptance and commitment therapy (ACT) and self-compassion training. Participants’ adherence and their satisfaction were also studied.

CLINICAL STUDY

#mobile app

#platform

View Analyst & Ambassador Comments
Go to original news
Feb 17,2021

Dr. Ofer Sharon, CEO of OncoHost, Discusses Technology to Improve Cancer Care

DocWire News recently spoke with Dr. Ofer Sharon, CEO of OncoHost, a company that combines life-science research and advanced machine learning technology to develop personalized strategies to maximize the success of cancer therapy. See what Dr. Sharon had to say.

View Analyst & Ambassador Comments
Go to original news
Mar 24,2021

Vinehealth listed as one of the top 15 health and fitness entrepreneurs to watch in 2021 in the Great British Entrepreneur Awards

Vinehealth is thrilled to be listed in top 15 health and fitness entrepreneurs in the Great British Entrepreneur Awards in partnership with Starling Bank.

View Analyst & Ambassador Comments
Go to original news
Mar 08,2021

Vinehealth named one of 12 high impact innovations to join the NHS England’s National Innovation Accelerator in 2021

The NHS Innovation Accelerator (NIA) announces the 12 innovators and innovations selected to join its award-winning programme in 2021. These innovations offer solutions to some of the NHS’ most pressing needs and will be supported over the next three years to scale across England for the benefit of NHS patients and staff. Vinehealth is delighted to have been successfully selected for the 2021 cohort. The next step for the Company is to undertake projects across the UK which Vinehealth is excited to be working collaboratively with the Academic Health Science Networks (AHSN )to deliver.

COLLABORATION PARTNERSHIP

#r&d

#mobile app

#rwe

View Analyst & Ambassador Comments
Go to original news
Mar 09,2021

Alternative or Complementary Cancer Treatment

Cancer patients these days are well-informed and educated about their condition. As they are more proactive about their treatment, it’s common to find resources online that promote alternative or complementary practices. These are used to treat or alleviate cancer symptoms. Many online cancer communities like belong.life can be an excellent source of information on these matters. By choosing a reliable source, a cancer patient will get unbiased and factual information. Also, online communities with a vast network of professionals and like-minded individuals can help in decision-making.

View Analyst & Ambassador Comments
Go to original news
Mar 02,2021

Ongoing Innovation, Patient-First Approach Drives Successful 2020 for OncoHealth

OncoHealth, the leading digital health company focused on the physical, mental and financial complexities of cancer care, leveraged an ongoing commitment to innovation and patient-first treatment approach to achieve key growth milestones for fiscal year 2020. Company increased revenue YOY by 40%, delivered over $100 million of financial impact to clients, and added 1.1 million incremental new members on prior auth platform.

View Analyst & Ambassador Comments
Go to original news
Subscribe to ONCOLOGY